VYNE Therapeutics Inc. - VYNE
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 14
Latest filed: Jul 02, 2026
| Form | Count |
|---|---|
| 4 | 9 |
| 8-K | 3 |
| SCHEDULE 13G | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Jul 02, 2026 | 4 | Jun 30, 2026 | 0001727794-26-000008 | View |
| Jul 02, 2026 | 4 | Jun 30, 2026 | 0001727756-26-000006 | View |
| Jul 02, 2026 | 4 | Jun 30, 2026 | 0001727809-26-000006 | View |
| Jul 02, 2026 | 4 | Jun 30, 2026 | 0001867033-26-000006 | View |
| Jun 15, 2026 | SCHEDULE 13G | — | 0002140685-26-000001 | View |
| Jun 02, 2026 | 4 | May 29, 2026 | 0001727794-26-000006 | View |
| May 21, 2026 | 8-K | May 21, 2026 | 0001104659-26-065214 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0001104659-26-062664 | View |
| Apr 02, 2026 | 4 | Mar 31, 2026 | 0001727794-26-000004 | View |
| Apr 02, 2026 | 4 | Mar 31, 2026 | 0001727809-26-000004 | View |
| Apr 02, 2026 | 4 | Mar 31, 2026 | 0001727756-26-000004 | View |
| Apr 02, 2026 | 4 | Mar 31, 2026 | 0001867033-26-000004 | View |
| Mar 11, 2026 | 8-K | Mar 11, 2026 | 0001104659-26-026439 | View |
| Jan 30, 2026 | 8-K | Jan 30, 2026 | 0001104659-26-008642 | View |